1. Home
  2. TARS vs VYX Comparison

TARS vs VYX Comparison

Compare TARS & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • VYX
  • Stock Information
  • Founded
  • TARS 2016
  • VYX 1881
  • Country
  • TARS United States
  • VYX United States
  • Employees
  • TARS N/A
  • VYX N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • VYX
  • Sector
  • TARS Health Care
  • VYX
  • Exchange
  • TARS Nasdaq
  • VYX Nasdaq
  • Market Cap
  • TARS 1.7B
  • VYX 1.8B
  • IPO Year
  • TARS 2020
  • VYX N/A
  • Fundamental
  • Price
  • TARS $57.25
  • VYX $13.72
  • Analyst Decision
  • TARS Strong Buy
  • VYX Strong Buy
  • Analyst Count
  • TARS 7
  • VYX 5
  • Target Price
  • TARS $67.14
  • VYX $14.20
  • AVG Volume (30 Days)
  • TARS 737.4K
  • VYX 1.9M
  • Earning Date
  • TARS 08-06-2025
  • VYX 08-07-2025
  • Dividend Yield
  • TARS N/A
  • VYX N/A
  • EPS Growth
  • TARS N/A
  • VYX N/A
  • EPS
  • TARS N/A
  • VYX 7.32
  • Revenue
  • TARS $295,521,000.00
  • VYX $2,677,000,000.00
  • Revenue This Year
  • TARS $122.94
  • VYX N/A
  • Revenue Next Year
  • TARS $44.14
  • VYX N/A
  • P/E Ratio
  • TARS N/A
  • VYX $1.83
  • Revenue Growth
  • TARS 254.45
  • VYX N/A
  • 52 Week Low
  • TARS $25.14
  • VYX $7.55
  • 52 Week High
  • TARS $57.60
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • TARS 79.79
  • VYX 60.46
  • Support Level
  • TARS $53.15
  • VYX $12.31
  • Resistance Level
  • TARS $55.17
  • VYX $12.97
  • Average True Range (ATR)
  • TARS 2.03
  • VYX 0.50
  • MACD
  • TARS 0.89
  • VYX 0.02
  • Stochastic Oscillator
  • TARS 97.95
  • VYX 95.29

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: